SBRA Stock Analysis: Buy, Sell, or Hold?
SBRA - Sabra Healthcare REIT, Inc.
$18.27
0.15 (0.83%)
▲
5d:
-2.46%
30d:
-13.25%
90d:
-6.74%
HOLD
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 03, 2026
Get Alerted When SBRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SBRA shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SBRA shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$26.58
Based on 7.4% avg growth
INTRINSIC VALUE TODAY
$16.50
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SBRA is currently trading at $18.27, which is considered slightly low relative to its 30-day fair value range of $18.22 to $20.57. The stock's valuation (Forward PE: 24.6) is in line with its historical norms (25.7). Remarkably, the market is currently pricing in an annual earnings decline of 1.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SBRA is in a strong uptrend. Immediate support is located at $17.54, while resistance sits at $20.78.
Market Sentiment: SBRA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $22.54 (+23.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SBRA is in a strong uptrend. Immediate support is located at $17.54, while resistance sits at $20.78.
Market Sentiment: SBRA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $22.54 (+23.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$18.22 -
$20.57
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.4% below Wall St target ($22.54)
Trading Range Analysis
30-Day Trading Range
$18.22 -
$20.57
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$17.54
Resistance Level
$20.78
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.58
Wall Street Target
$22.54
(+23.4%)
Revenue Growth (YoY)
21.7%
Earnings Growth (YoY)
-5.6%
Profit Margin
19.1%
Valuation Discount vs History
-1.5% cheaper
PE vs Historical
24.6 vs 25.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.5%
(market-implied from PE analysis)
1-Year Target
$18.00
(-2%)
2-Year Target
$17.73
(-3%)
3-Year Target
$17.46
(-4%)
3-Yr Target (if PE normalizes)
(PE: 25→26)
$18.26
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.6, Growth: 10.9%)
$24.95
(+37%)
Base:
(SPY PE: 21.8, Growth: 10.9%)
$22.10
(+21%)
Bear:
(PE: 18.5, Growth: 10.9%)
$18.79
(+3%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (29x PE), but valuation improves significantly next year (25x PE) as earnings recover.
Trailing PE: 28.76 | Current EPS (TTM): $0.63
Bull Case
$23.52
(+29%)
Analyst growth 18.0%, PE expands to 31.6
Base Case
$21.38
(+17%)
Market implied 18.0%, PE stable at 28.8
Bear Case
$12.32
(-33%)
Severe decline -20.0%, PE contracts to 24.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 24.6 to 25.7
Stabilization Target:
$19.10
(+4.6%)
PE Expansion Potential:
+4.6%
Share & Embed Analysis
Last updated: June 23, 2026 8:23 AM ET
Data refreshes hourly during market hours. Next update: 9:23 AM
Data refreshes hourly during market hours. Next update: 9:23 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated REIT - Healthcare Facilities Stocks
Top-rated stocks in REIT - Healthcare Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VTR
Ventas Inc |
STRONG BUY
20 analysts |
$97 | 57 HOLD |
|
WELL
Welltower Inc |
STRONG BUY
20 analysts |
$235 | 60 HOLD |
|
DOC
Healthpeak Properties Inc |
STRONG BUY
20 analysts |
$21 | 57 HOLD |
|
STRW
Strawberry Fields REIT L… |
STRONG BUY
7 analysts |
$15 | 60 HOLD |
|
AHR
American Healthcare REIT… |
STRONG BUY
9 analysts |
$58 | 53 HOLD |
